<p>The present invention concerns a mammalian cell lacking GlcNAc transferase I activity, engineered to express an antibody or a fragment thereof, thereby enhancing the antibody dependent cell mediated cytotoxicity (ADCC) exhibited by the expressed antibody or fragment thereof.</p>